No connection

Search Results

MRSH

NEUTRAL
$170.83 Live
Marsh & McLennan Companies, Inc. · NYSE
Target $203.09 (+18.9%)
$164.89 52W Range $235.78

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 30, 2026
Market cap
$82.3B
P/E
21.38
ROE
27.6%
Profit margin
14.3%
Debt/Equity
1.52
Dividend yield
2.11%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
MRSH demonstrates stable operational health with a Piotroski F-Score of 6/9 and a strong ROE of 27.57%, yet it trades at a massive premium to its Graham Number ($73.7) and Intrinsic Value ($55.93). While the company has an exceptional 25-quarter track record of beating earnings estimates, recent YoY earnings growth has contracted by 15.4%. Bearish insider activity, specifically from the CEO, and a 0/100 technical trend suggest significant short-term headwinds despite a 'Buy' analyst consensus. The stock is a high-quality business currently suffering from a valuation disconnect and decelerating earnings momentum.

Key Strengths

Exceptional earnings track record with beats in nearly all of the last 25 quarters
Strong profitability with an ROE of 27.57% and Operating Margin of 24.34%
Stable financial health as indicated by a Piotroski F-Score of 6/9
Sustainable dividend profile with a conservative payout ratio of 43.94%
Consistent revenue growth (7.60% YoY) indicating steady top-line demand

Key Risks

Severe overvaluation relative to Graham Number ($73.7) and Intrinsic Value ($55.93)
Negative earnings growth (-15.4% YoY and -17.0% Q/Q)
Bearish insider sentiment with multiple sales by the CEO and officers
Weak liquidity profile indicated by a Quick Ratio of 0.51
Strong negative price momentum with a 21.6% decline over the last year
AI Fair Value Estimate
Based on comprehensive analysis
$115.0
-32.7% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
58
Moderate
Value
30
Future
45
Past
90
Health
65
Dividend
60
AI Verdict
Quality business, poor entry value
Key drivers: High ROE, Earnings contraction, Valuation premium, Insider selling
Confidence
90%
Value
30/100

Ref P/E 21.38, PEG 1.67, Graham Number $73.7

Positives
  • Forward P/E (15.10) is lower than current P/E
Watchpoints
  • Current price ($170.83) is >2x the Graham Number ($73.7)
  • Price/Book of 5.65 is elevated
Future
45/100

Ref Growth rates

Positives
  • Steady revenue growth of 7.6%
Watchpoints
  • Negative YoY earnings growth (-15.4%)
  • Negative Q/Q earnings growth (-17.0%)
Past
90/100

Ref Historical trends

Positives
  • Consistent EPS beats over 25 quarters
  • Long-term 5Y price change of +35.8%
Watchpoints
  • Recent 1Y performance is sharply negative (-21.6%)
Health
65/100

Ref Piotroski F-Score 6/9

Positives
  • Piotroski F-Score of 6/9 (Stable)
  • Strong ROA of 7.27%
Watchpoints
  • Debt/Equity of 1.52 is slightly above sector average
  • Quick Ratio of 0.51 suggests tight short-term liquidity
Dividend
60/100

Ref Yield 2.11%, Payout 43.94%

Positives
  • Sustainable payout ratio (43.94%)
Watchpoints
  • Relatively low dividend yield (2.11%)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$170.83
Analyst Target
$203.09
Upside/Downside
+18.9%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for MRSH and closest competitors.

Updated 2026-04-29
MRS
Marsh & McLennan Companies, Inc.
Primary
5Y
+35.8%
3Y
-1.3%
1Y
-21.6%
6M
-4.1%
1M
-1.7%
1W
-2.7%
BAM
Brookfield Asset Management Ltd.
Peer
5Y
+77.9%
3Y
+76.8%
1Y
-9.3%
6M
-17.4%
1M
-4.2%
1W
-2.9%
ING
ING Groep N.V.
Peer
5Y
+206.0%
3Y
+172.3%
1Y
+49.4%
6M
+19.5%
1M
+17.0%
1W
-1.4%
PNC
The PNC Financial Services Group, Inc.
Peer
5Y
+41.8%
3Y
+89.3%
1Y
+24.6%
6M
+7.5%
1M
-2.0%
1W
+1.9%
ICE
Intercontinental Exchange, Inc.
Peer
5Y
+62.6%
3Y
+50.6%
1Y
-1.7%
6M
-13.2%
1M
-3.4%
1W
+2.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
21.38
Forward P/E
15.1
PEG Ratio
1.67
P/B Ratio
5.65
P/S Ratio
2.99
EV/Revenue
3.76
EV/EBITDA
13.55
Market Cap
$82.3B

Profitability

Profit margins and return metrics

Profit Margin 14.26%
Operating Margin 24.34%
Gross Margin 43.85%
ROE 27.57%
ROA 7.27%

Growth

Revenue and earnings growth rates

Revenue Growth +7.6%
Earnings Growth -15.4%
Q/Q Revenue Growth +7.59%
Q/Q Earnings Growth -17.0%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
1.52
High debt
Current Ratio
1.11
Good
Quick Ratio
0.51
Poor
Cash/Share
$3.34

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q1 2026

Revenue
$7.6B
Gross Margin
45.6%
Op. Margin
23.1%
Net Margin
15.1%
Total Assets
$58.6B
Liabilities
$43.7B
Equity
$14.6B
Debt/Equity
3.00x
Operating CF
$-0.7B
CapEx
$-0.1B
Free Cash Flow
$-0.8B
FCF Yield
109%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-07-16
$N/A
2026-04-16
$3.29
+2.1% surprise
2026-01-29
$1.68
+1.4% surprise
2025-10-16
$1.85
+4.1% surprise

Financial Services Sector Comparison

Comparing MRSH against 915 companies in the Financial Services sector (148 bullish, 394 neutral, 373 bearish)
P/E Ratio
21.38
This Stock
vs
34.57
Sector Avg
-38.1% (Discount)
Return on Equity (ROE)
27.57%
This Stock
vs
0.12%
Sector Avg
+22815.5% (Excellent)
Profit Margin
14.26%
This Stock
vs
92.09%
Sector Avg
-84.5% (Weaker)
Debt to Equity
1.52
This Stock
vs
1.29
Sector Avg
+17.7% (Higher)
Revenue Growth
7.6%
This Stock
vs
33.99%
Sector Avg
-77.6% (Slower)
Current Ratio
1.11
This Stock
vs
3.02
Sector Avg
-63.2% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

TOMLINSON PATRICK
Officer
Stock Award
2026-03-13
1,228 shares
JONES JOHN JUDE
Officer
Sell
2026-03-11
2,362 shares · $410,067
DOYLE JOHN Q
Chief Executive Officer
Sell
2026-03-04
16,655 shares · $3,052,862
DOYLE JOHN Q
Chief Executive Officer
Stock Award
2026-03-04
16,655 shares
STUDER NICHOLAS MARK
Officer
Sell
2026-03-03
3,837 shares · $706,123
DOYLE JOHN Q
Chief Executive Officer
Stock Award
2026-02-27
59,510 shares
MILLS STACY
Officer
Stock Award
2026-02-27
2,723 shares
FERNANDEZ CARMEN
Officer
Stock Award
2026-02-27
6,970 shares
BESWICK PAUL
Chief Technology Officer
Stock Award
2026-02-27
6,970 shares
STUDER NICHOLAS MARK
Chief Executive Officer
Stock Award
2026-02-27
8,044 shares
KLISURA DEAN MICHAEL
Officer
Stock Award
2026-02-27
9,383 shares
SOUTH MARTIN
Chief Executive Officer
Stock Award
2026-02-27
14,476 shares
BRENNAN KATHERINE J.
General Counsel
Stock Award
2026-02-27
6,970 shares
JONES JOHN JUDE
Officer
Stock Award
2026-02-27
4,826 shares
TOMLINSON PATRICK
Officer
Stock Award
2026-02-27
2,219 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-16

MRSH filed an 8-K on April 16, 2026, likely to announce its first-quarter financial results.

10-Q
10-Q
2026-04-16

The provided 10-Q filing for MRSH, dated April 16, 2026, contains no specific financial highlights in the available excerpt. The document includes a section dedicated to risk factors, although the specific nature of these risks is not detailed in the provided text.

8-K
FORM 8-K
2026-04-14

MRSH filed an 8-K on April 14, 2026, likely to announce its first-quarter financial results.

DEF 14A
DEF 14A
2026-03-31

MRSH filed a definitive proxy statement on March 31, 2026, providing shareholders with necessary information and voting materials for an upcoming meeting.

8-K
8-K
2026-03-10
8-K
8-K
2026-02-25

MRSH filed an 8-K likely announcing its annual financial results for the fiscal year ended December 31, 2025.

8-K
8-K
2026-02-19

MRSH filed an 8-K on February 19, 2026, likely to announce its financial results for the most recent fiscal period.

10-K
10-K
2026-02-09

MRSH filed its 10-K on February 9, 2026, which includes standard regulatory disclosures regarding its financial condition, market risks, and operational results. While specific financial metrics were not provided in the excerpts, the filing contains dedicated sections for risk factors, cybersecurity, and management's discussion and analysis.

8-K
8-K
2026-01-29

MRSH filed an 8-K on January 29, 2026, likely to announce its quarterly financial results.

8-K
8-K
2026-01-14

MRSH filed an 8-K on January 14, 2026, likely to announce its fourth quarter and full-year financial results.

10-Q
10-Q
2025-10-16
8-K
8-K
2025-10-16
10-Q
10-Q
2025-07-17
8-K
8-K
2025-07-17
8-K
8-K
2025-07-09
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
21 analysts
Keefe, Bruyette & Woods
2026-04-17
Maintains
Market Perform Market Perform
B of A Securities
2026-04-14
Maintains
Underperform Underperform
Mizuho
2026-04-13
Maintains
Neutral Neutral
JP Morgan
2026-04-09
Maintains
Overweight Overweight
Wells Fargo
2026-04-09
Maintains
Equal-Weight Equal-Weight
Barclays
2026-04-08
Maintains
Overweight Overweight
Keefe, Bruyette & Woods
2026-04-07
Maintains
Market Perform Market Perform
Morgan Stanley
2026-04-06
Maintains
Equal-Weight Equal-Weight
Barclays
2026-03-11
Maintains
Overweight Overweight
Mizuho
2026-02-27
down
Outperform Neutral

Past News Coverage

Recent headlines mentioning MRSH from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile